Pharus Diagnostics

Zhubei City, Taiwan · Founded 2022 · Privately Held (backing)

Developer and provider of liquid biopsy tests intended for the early detection of cancer. Pharus Diagnostics is based in Zhubei City, Taiwan and was founded in 2022. Its last reported valuation was $43 million in Apr 2025. It has raised $17.1 million.

Last reported valuation

$43.0M

Oct 2026

Priced at

—

Total raised

$17.1M

Last round

—

How much has Pharus Diagnostics raised?

$17.1Macross 0 recorded rounds

Free account

More of Pharus Diagnostics with a free account

·Watch Pharus Diagnostics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Pharus Diagnostics investors

5 investors are on record for Pharus Diagnostics, including Lee Family Office, CK Hutchison, CK Life Sciences International and Larta Institute.

For fundraisers

Raising for a company like Pharus Diagnostics?

5 investors have backed Pharus Diagnostics.

See all 5 investors →

Frequently asked about Pharus Diagnostics

How much has Pharus Diagnostics raised?: Pharus Diagnostics has raised $17.1M in total across 0 recorded funding rounds.